France· FR:60418851
LAMIDERM 0,67 POUR CENT, émulsion pour application cutanée
A trolamine product containing trolamine, registered in France by GIFRER BARBEZAT. The same ATC class is registered in 2 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Trolamine is registered in 2 of 19 countries.
Countries holding a registration under ATC D03AX12 (trolamine), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 1 of them publish a price we can compare per daily dose
Trolamine · ATC D03AX12
2 / 19 countries
- Franceprice
- Germany
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TROLAMINE
- Manufacturer
- GIFRER BARBEZAT
- Country
- France (FR)
- ATC code
- D03AX12
- ATC class
- Trolamine
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 3
- cip1334009354406001 tube(s) aluminium de 200 ml
- cip1334009361709571 tube(s) aluminium de 140 ml
- cip1334009394355891 tube(s) aluminium de 80 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Trolamine in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Germany · Triethanolamin Smartpractice Europe
- Luxembourg · Biafine
- Malta · Biafine
- Portugal · Biafine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b2d1f026-c1d7-438d-a519-81e7225d0e52 GET /v1/drugs/b2d1f026-c1d7-438d-a519-81e7225d0e52?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60418851",
"date_amm": "2000-05-03",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "TROLAMINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "émulsion pour application",
"voies_administration": "cutanée",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about trolamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.